Browse: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 1 | 3 |
Genentech, Inc. patentsThe following is a sampling of recent Genentech, Inc. patent applications (USPTO Patent Application #, Patent Title) sorted by month.
July 2009 - Genentech, Inc. patents
20090175854 - Methods of using death receptor ligands and cd20 antibodies
20090175855 - Novel compositions and methods for the treatment of immune related diseases
20090175865 - Cysteine engineered antibodies and conjugates
20090176822 - Pyrrolidine inhibitors of iap
20090169550 - Therapy of rituximab-refractory rheumatoid arthritis patients
20090169556 - Vascular endothelial cell growth factor antagonists
20090169569 - Apo-2l receptor agonist and cpt-11 synergism
June 2009 - Genentech, Inc. patents
20090162364 - Apo-2 ligand
20090162364 - Apo-2 ligand
20090163419 - Human growth hormone aqueous formulation
20090163419 - Human growth hormone aqueous formulation
20090155247 - Methods of using death receptor agonists and egfr inhibitors
20090155259 - Extending time to disease progression or survival in cancer patients
20090155807 - C-met mutations in lung cancer
20090148435 - Antibody purification by cation exchange chromatography
20090148448 - Methods and compositions for modulating and detecting wisp activity
20090148457 - Hepatocyte growth factor receptor antagonists and uses thereof
20090148921 - Compositions and methods for enhancing apoptosis
20090142259 - Compositions and methods for the diagnosis and treatment of bladder and urinary tract tumors
20090142348 - Novel gene disruptions, compositions and methods relating thereto
20090142786 - Secreted and transmembrane polypeptides and nucleic acids encoding the same
May 2009 - Genentech, Inc. patents
20090136492 - Therapy of ocular disorders
20090136997 - Pro1550 polypeptides and nucleic acids encoding the same
20090137476 - Apo-2 ligand variants and uses thereof
20090131407 - Tetracyclic kinase inhibitors
20090123930 - Methods and compositions for diagnostic use in cancer patients
April 2009 - Genentech, Inc. patents
20090098112 - Novel antibodies
20090087426 - Methods for treatment of allergic asthma
20090087426 - Methods for treatment of allergic asthma
20090087428 - Anti-fc-gamma riib receptor antibody and uses therefor
20090087428 - Anti-fc-gamma riib receptor antibody and uses therefor
March 2009 - Genentech, Inc. patents
20090081223 - Fixed dosing of her antibodies
20090081229 - Anti-pro87299 antibodies
20090081232 - Methods of treating diseases with anti-vegf antibodies
20090083866 - Transgenic rosa26-luciferase mice for bioluminescent imaging
20090075317 - Methods and compositions for modulating hepatocyte growth factor activation
20090068110 - Antibodies to insulin-like growth factor receptor
20090068178 - Compositions and methods for the treatment of tumor of hematopoietic origin
February 2009 - Genentech, Inc. patents
20090053216 - Treatment with anti-vegf antibodies
20090053230 - Anti-ox40l antibodies and methods using same
20090054624 - Pro1190 polypeptides
20090054631 - Compositions and methods for treatment of non-hodgkin's lymphoma
20090047291 - Modulators of hepatocyte growth factor activator
20090048313 - 2-amido-thiazole-based compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof
20090041742 - Human dnase ii
20090041749 - Compositions and methods for the diagnosis and treatment of tumor
20090041788 - Apo-2l receptor agonist and cpt-11 synergism
January 2009 - Genentech, Inc. patents
20090028856 - Anti-cd79b antibodies and immunoconjugates and methods of use
20090022713 - Anti-pro87299 antibodies
20090023602 - Binding polypeptides with restricted diversity sequences
20090010881 - Treatment with anti-vegf antibodies
20090010883 - Treatment with anti-vegf antibodies
20090010924 - Apoptotic anti-ige antibodies
20090010925 - Antibody variants
20090012003 - Polypeptides homologous to vegf and bmp1
20090004189 - Biological markers predictive of rheumatoid arthritis response to b-cell antagonists
20090004204 - Assays and methods using biomarkers
October 2008 - Genentech, Inc. patents
20080254024 - Anti-ephb2 antibodies and methods using same
20080247951 - Anti-robo4 antibodies and uses therefor
20080248036 - Treatment with anti-vegf antibodies
20080248037 - Dr5 antibodies and uses thereof
20080248049 - Treatment with anti-vegf antibodies
20080241143 - Inhibition of leukocyte adhesion
20080241146 - Apo-2 ligand-anti-her-2 antibody synergism
20080241148 - Treatment with anti-vegf antibodies
20080241159 - Methods and compositions for selective modulation of vascularization
20080242655 - Aza-indolyl compounds and methods of use
20080242709 - 2-amido-4-isoxazolyl thiazole compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof
September 2008 - Genentech, Inc. patents
20080233646 - Human dr4 antibodies and uses thereof
20080226621 - Antagonist anti-notch3 antibodies and their use in the prevention and treatment of notch3-related diseases
20080226629 - Anti-vegf antibodies
20080227119 - Elisa for vegf
20080220471 - Vectors and methods using same
20080221014 - Method of diagnosing and treating glioma
20080213268 - Neuropilin antagonists
20080213280 - Therapy of autoimmune disease in a patient with an inadequate response to a tnf-alpha inhibitor
20080213837 - Apo-3 ligand polypeptide
August 2008 - Genentech, Inc. patents
20080206243 - Methods for treating kidney disorders
20080199423 - Methods of using apo2l receptor agonists and ink cell activators
20080199464 - Combination therapy with angiogenesis inhibitors
20080200375 - Angiogenesis using hepatocyte growth factor
20080193446 - Compositions and methods for the diagnosis and treatment of tumor
20080193981 - Polyelectrolyte precipitation and purification of proteins
20080187533 - Treatment with anti-erbb2 antibodies
20080187534 - Anti-vegf antibodies
July 2008 - Genentech, Inc. patents
20080181900 - Vascular endothelial cell growth factor antagonists
20080182277 - Assays and methods using biomarkers
20080175847 - Anti-dll4 antibodies and methods using same
20080176286 - Method for making monoclonal antibodies and cross-reactive antibodies obtainanble by the method
20080176257 - Assay for antibodies
20080176788 - Apo-2 ligand
20080171037 - Apo-3 ligand polypeptide
20080171040 - Antibody-drug conjugates and methods
20080166294 - Compositions and methods for the treatment of tumor of hematopoietic origin
20080166351 - Treatment with anti-vegf antibodies
20080167386 - Disheveled pdz modulators
20080160026 - Apo-2 ligand-anti-her-2 antibody synergism
20080160029 - Treatment with anti-vegf antibodies
20080160034 - Novel gene disruptions, compositions and methods relating thereto
20080160572 - Aminopeptidase
June 2008 - Genentech, Inc. patents
20080146808 - Azabicyclo-octane inhibitors of iap
20080138338 - Polypeptide variants
20080131908 - Novel anti-notch3 antibodies and their use in the detection and diagnosis of disease
May 2008 - Genentech, Inc. patents
20080124331 - Compositions and methods for the diagnosis and treatment of tumor
20080124344 - Novel gene disruptions, compositions and methods relating thereto
20080124765 - Expression of functional antibody fragments
20080125580 - Refolding of recombinant proteins
20080118506 - Humanized anti-factor d antibodies and uses thereof
20080118520 - Anti-notch3 agonist antibodies and their use in the treatment of notch3-related diseases
20080112958 - Gene detection assay for improving the likelihood of an effective response to an erbb antagonist cancer therapy
20080107641 - Method of treating stroke with thrombolytic agent
20080102072 - Monoclonal antibodies to type i interferon receptor
20080102468 - Compositions and methods for treatment of non-hodgkin's lymphoma
April 2008 - Genentech, Inc. patents
20080095771 - Treatment method
20080095773 - Polypeptides homologous to vegf and bmp1
20080096215 - Compositions and methods for the diagnosis and treatment of tumor
20080085886 - Aza-benzofuranyl compounds and methods of use
20080081821 - Aza-benzothiophenyl compounds and methods of use
March 2008 - Genentech, Inc. patents
20080075719 - Method for augmenting b cell depletion
20080063641 - Monovalent antibody fragments useful as therapeutics
20080057066 - Methods and compositions for targeting relt
20080057503 - Methods and compositions for detecting autoimmune disorders
February 2008 - Genentech, Inc. patents
20080050310 - Antibodies and immunoconjugates and uses therefor
20080050364 - Treatment of lfa-1 associated disorders with increasing doses of lfa-1 antagonist
20080050373 - Treatment with anti-erbb2 antibodies
20080050377 - Compositions and methods relating to stop-1
20080050758 - Secreted and transmembrane polypeptides and nucleic acids encoding the same
20080044415 - Hepatocyte growth factor receptor antagonists and uses thereof
20080044421 - Methods of using death receptor ligands and cd20 antibodies
20080038264 - Compositions and methods for the treatment of immune related diseases
20080038717 - Enrichment method for variant proteins with altered binding properties
20080031875 - Treatment method
20080031880 - Use of erbb receptor ligands in treating diabetes
20080032343 - Recombinant production of heparin binding proteins
January 2008 - Genentech, Inc. patents
20080025971 - Humanized anti-beta7 antagonists and uses therefor
20080026426 - Anti-infective therapy
20080014196 - Compositions and methods for modulating vascular development
20080008705 - Cancer prognostic diagnostic and treatment methods
20080003218 - Anti-ige antibodies
December 2007 - Genentech, Inc. patents
20070298036 - Pro71238 polypeptides
20070299052 - Inhibitors of iap
20070292419 - Treatment with anti-erbb2 antibodies
20070292438 - Novel gene disruptions, compositions and methods relating thereto
20070292936 - Binding polypeptides with optimized scaffolds
20070280931 - Antibody variants
November 2007 - Genentech, Inc. patents
20070274995 - Cardiotrophin-1 compositions and methods for the treatment of tumor
20070269371 - Antibodies with altered effector functions
20070269429 - Treatment with anti-erbb2 antibodies
20070269446 - Compositions and methods for the treatment of tumor of hematopoietic origin
20070264193 - Diagnostics and treatments for tumors
20070264259 - Methods for treating kidney disorders
20070264267 - Compositions and methods for treatment of cancer
20070264686 - Secreted and transmembrane polypeptides and nucleic acids encoding the same
20070258984 - Treatment with anti-vegf antibodies
20070259398 - Microwave assisted deglycosylation of proteins for molecular weight determination by mass spectrometry
20070253948 - Anti-fc-gamma riib receptor antibody and uses therefor
20070253959 - Vascular endothelial cell growth factor antagonists
20070254302 - Compositions and methods for the diagnosis and treatment of tumor
October 2007 - Genentech, Inc. patents
20070248588 - Novel compositions and methods for the treatment of immune-related diseases
20070248604 - Anti-fgf19 antibodies and methods using same
20070248610 - Anti-vegf antibodies
20070250941 - Vegf receptor conditional knockout animals and methods of use
20070243193 - Compositions and methods for the diagnosis and treatment of tumor
20070237774 - Method for using boc/cdo to modulate hedgehog signaling
20070238642 - Production of vascular endothelial cell growth factor and dna encoding same
20070238859 - Pro9925 polypeptides
20070231323 - Compositions and methods for the diagnosis and treatment of tumors of glial origin
20070231324 - Methods of using death receptor ligands and cd20 antibodies
20070231328 - Method of treatment using humanized anti-cd11a antibodies
September 2007 - Genentech, Inc. patents
20070224185 - Secreted and transmembrane polypeptides and nucleic acids encoding the same
20070224201 - Compositions and methods for the diagnosis and treatment of tumor
20070218069 - Methods and compositions for targeting polyubiquitin
20070212356 - Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling
20070212362 - Use of il-17 antibody for the treatment of cartilage damaged by osteoarthritis
20070212735 - Compositions and methods for the diagnosis and treatment of tumor
20070207142 - Compositions and methods for the treatment of tumor of hematopoietic origin
20070207147 - Secreted and transmembrane polypeptides and nucleic acids encoding the same
August 2007 - Genentech, Inc. patents
20070202045 - Serum albumin binding peptides for tumor targeting
20070202516 - Gene detection assay for improving the likelihood of an effective response to an egfr antagonist cancer therapy
20070196374 - Anti-vegf antibodies
20070190058 - Method for treating intraocular neovascular diseases
20070184055 - Treatment with anti-erbb2 antibodies
20070184444 - Compositions and methods for the treatment of immune related diseases
20070185017 - Compositions and methods for the treatment of immune related diseases
20070178486 - Compositions and methods for the diagnosis and treatment of tumor
20070178539 - Novel cytokine receptors and nucleic acids encoding the same
20070179088 - Foggy
20070179091 - Hedgehog kinases and their use in modulating hedgehog signaling
July 2007 - Genentech, Inc. patents
20070174922 - Nucleic acid encoding novel type-1 cytokine receptor glm-r
20070166753 - Gene detection assay for improving the likelihood of an effective response to a her2 antibody cancer therapy
20070160576 - Il-17a/f heterologous polypeptides and therapeutic uses thereof
20070160594 - Method of diagnosing and treating cartilaginous disorders
20070160598 - Binding polypeptides with diversified and consensus vh/vl hypervariable sequences
20070160608 - Treatment with anti-vegf antibodies
20070160612 - Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders
20070160618 - Cardiotrophin-1 compositions and methods for the treatment of tumor
20070161061 - Novel composition and methods for the treatment of immune related diseases
20070161558 - Production of vascular endothelial cell growth factor and dna encoding same
20070161564 - Methods for making apo-2 ligand using divalent metal ions
20070154391 - Antibodies to vascular endothelial cell growth factor
20070154483 - Treatment with anti-vegf antibodies
June 2007 - Genentech, Inc. patents
20070148177 - Treatment with anti-vegf antibodies
20070148178 - Treatment with anti-vegf antibodies
20070141023 - Assays and methods using biomarkers
20070141066 - Method for diagnosing, prognosing and treating glioma
20070141068 - Methods for the treatment of carcinoma
20070141630 - Identification of non-covalent complexes by mass spectrometry
20070143871 - Non-human transgenic animal models for hepatocellular carcinoma
20070134243 - Antibody drug conjugates and methods
20070134251 - Assays and methods using biomarkers
20070136829 - Novel type-1 cytokine receptor glm-r
20070129301 - Methods and compositions for modulating hgf/met
May 2007 - Genentech, Inc. patents
20070122394 - Compositions and methods for liver growth and liver protection
20070122407 - Isolated nucleic acids, vectors and host cells encoding erbb3 antibodies
20070116700 - Reduced-viscosity concentrated protein formulations
20070117124 - Achaete-scute like-2 polypeptides and encoding nucleic acids and methods for the diagnosis and treatment of tumor
20070110755 - Vascular endothelial cell growth factor antagonists
20070098634 - Compositions and methods for the diagnosis and treatment of tumor
20070098681 - Apo-2 ligand/trail variants and uses thereof
20070098707 - Methods and compositions for inhibiting c-met dimerization and activation
April 2007 - Genentech, Inc. patents
20070092520 - Humanized anti-cmet antagonists
20070092890 - Methods and compositions for detecting autoimmune disorders
20070092940 - Cysteine engineered antibodies and conjugates
20070086995 - Methods of treating ige-mediated disorders comprising the administration of high concentration anti-ige antibody formulations
20070087006 - Compositions and methods for the diagnosis and treatment of tumor
20070081995 - Methods and compositions for targeting ifnar2
20070077243 - Method for making humanized antibodies
20070077625 - Purification of polypeptides
20070077626 - Polypeptides sharing sequence identity with a fibroblast growth factor polypeptide and nucleic acids encoding the same
March 2007 - Genentech, Inc. patents
20070048218 - Compositions and methods for the diagnosis and treatment of tumor
20070048301 - Compositions and methods for the treatment of immune related diseases
20070048326 - Compositions and methods for the diagnosis and treatment of tumor
20070048822 - Erbb4 receptor-specific neuregulin related ligands and uses therefor
20070048825 - Compositions and methods for the diagnosis and treatment of tumor
20070049516 - Use of insulin for the treatment of cartilaginous disorders
20070049601 - Benzofuran inhibitors of factor viia
20070049730 - Patched-2 antibodies
February 2007 - Genentech, Inc. patents
20070041969 - Apo-2dcr
20070041970 - Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders
20070041983 - Method for treating tumors using anti-osteopontin antibodies
20070042415 - Anti-fused antibodies
20070042395 - Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity
20070042466 - Il-1 related polypeptides
20070042945 - Nouvelles compositions et methods de traitement du psoriasis
20070036753 - Treatment with anti-vegf antibodies
20070036754 - Treatment with anti-vegf antibodies
20070036755 - Treatment with anti-vegf antibodies
20070036782 - Apo-2 ligand
20070036790 - Treatment with anti-vegf antibodies
20070036813 - Vegf-related protein
20070037148 - Compositions and methods for the treatmetn of natural killer cell related diseases
20070037191 - Apo-2dcr
20070037254 - Expression vectors and methods
20070037255 - Antibody variants with faster antigen association rates
20070037741 - Novel compositions and methods for the treatment of immune related disease
20070037813 - Serine protease inhibitors
20070037814 - Acylsulfamide inhibitors of factor viia
20070031331 - Treatment of disorders
20070031413 - Treatment with anti-vegf antibodies
20070031437 - Compositions and methods for modulating vascular development
20070031901 - Compositions and methods for the diagnosis and treatment of tumor
20070031929 - Polypeptides homologous to vegf and bmp1
20070025987 - Method for treating vasculitis
20070025988 - Method for treating lupus
20070025999 - Treatment with anti-vegf antibodies
20070026000 - Apo-2l receptor agonist and cpt-11 synergism
20070026001 - Apo-2 ligand-anti-her-2 antibody synergism
20070026002 - Inhibitors of angiopoietin-like 4 protein, combinations, and their use
20070026044 - Use of vegf for treating bone defects
20070026450 - Methods for the treatment of carcinoma
20070026496 - Process for producing polypeptides
20070027083 - Human growth hormone aqueous formulation
January 2007 - Genentech, Inc. patents
20070020256 - Methods for treatment of allergic asthma
20070020258 - Immunoglobulin variants
20070020260 - Glycoprotein compositions
20070020264 - Serum albumin binding peptides for tumor targeting
20070020276 - Methods for the treatment of carcinoma
20070021342 - Wound healing
20070014779 - Plasminogen activator variant formulations
20070014794 - Method for making heteromultimeric polypeptides
20070014797 - Method for treating sjogren's syndrome
20070015228 - Assay for antibodies
20070015247 - Method for making monoclonal antibodies and cross-reactive antibodies obtainable by the method
20070009523 - Polypeptide variants with altered effector function
20070010434 - Novel compositions and methods for the treatment of immune related diseases
20070004009 - Methods for making recombinant proteins using apoptosis inhibitors
December 2006 - Genentech, Inc. patents
20060292150 - Methods of using wisp antagonists
20060293235 - Hgf beta chain variants
20060286640 - Process for production of polypeptides
20060287234 - Wound healing
20060281146 - Novel compositions and methods for the treatment of immune related diseases
20060281680 - Methods and compositions for modulating vascular integrity
20060275306 - Protein formulation
20060276435 - Fibroblast activation protein inhibitor compounds and methods
November 2006 - Genentech, Inc. patents
20060270003 - Il-17a/f heterologous polypeptides and therapeutic uses thereof
20060270594 - Methods and compositions for modulating hyperstabilized c-met
20060263349 - Pretreatment of a biological sample from an autoimmune disease subject
20060263774 - Compositions and methods for the treatment of immune related diseases
20060263808 - C-met mutations in lung cancer
20060257390 - Catheter composition and uses thereof
20060257971 - Antibodies to pro1561 polypeptide
20060258574 - Novel compositions and methods for the treatment of psoriasis
20060251662 - Compositions and methods for the treatment of tumor of hematopoietic origin
20060246004 - Antibody variants and uses thereof
20060246050 - Catheter composition and uses thereof
20060246471 - Compositions and methods for screening pro-apoptotic compounds
October 2006 - Genentech, Inc. patents
20060240007 - Method for treating dementia or alzheimer's disease
20060240008 - Therapy of autoimmune disease in a patient with an inadequate response to a tnf-alpha inhibitor
20060233797 - Treatment of inflammatory bowel disease (ibd)
20060234306 - Assay method
20060228364 - Serum albumin binding peptides for tumor targeting
20060228745 - Gene detection assay for improving the likelhood of an effective response to an erbb antagonist cancer therapy
September 2006 - Genentech, Inc. patents
20060210556 - Novel composition and methods for the treatment of immune disorders
20060210561 - Dosages for treatment with anti-egfr antibodies
20060210570 - Methods and compositions for modulating prostasin
20060211612 - Angiogenesis using hepatocyte growth factor
20060204493 - Heteromultimeric molecules
20060198843 - Treatment with anti-erbb2 antibodies and chemotherapeutic agents
20060199181 - Compositions and methods for the treatment of immune related diseases
###
This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Genentech, Inc. in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Genentech, Inc. with additional patents listed. Browse our Agent directory for other possible listings.
###
FreshPatents.com Support
|
REGISTER now for FREE 
